Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation.

Related Articles

Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation.

J Immunol. 2011 Jun 15;186(12):6807-14

Authors: Morlacchi S, Dal Secco V, Soldani C, Glaichenhaus N, Viola A, Sarukhan A

Abstract
The clinical manipulation of regulatory T cells (Tregs) represents a promising strategy for the regulation of unwanted immune responses. It is now becoming clear that Tregs exert multiple effects on different cell targets under particular conditions; however, the interplay between these different factors remains unclear. Using mouse Tregs of known Ag specificity, we report in this study two different levels of Treg-mediated suppression: one that targets T cell proliferation and one that targets dendritic cell-mediated proinflammatory chemokine (CCL3 and CCL4) production. These two effects can be dissociated, and whereas modulation of T cell proliferation depends on the strength of the antigenic stimulus, modulation of chemokine production by dendritic cells does not. We also provide evidence that the bystander effect of Tregs on immune responses observed in vivo may be in great part explained by a decrease in the recruitment of target T cells, and therefore in the magnitude of the response, rather than by a direct effect on their priming or proliferation. Overall, our results shed some light on the different aspects that need to be considered when attempting to modulate Tregs for clinical purposes.

PMID: 21572026 [PubMed - indexed for MEDLINE]

Source: http://www.ncbi.nlm.nih.gov/PubMed/21572026?dopt=Abstract

natural products research natural products company products chemistry